• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ACADIA Pharmaceuticals Inc

+ Add to Watchlist

ACAD:US

19.4300 USD 0.1500 0.78%

As of 15:34:04 ET on 04/17/2014.

Company Profile for ACADIA Pharmaceuticals Inc (ACAD)

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Contact Information

ACADIA Pharmaceuticals Inc

3911 Sorrento Valley Boulevard
San Diego, CA 92121
United States
Phone: 1-858-558-2871
Fax: 1-858-558-2872

Key Executives for ACADIA Pharmaceuticals Inc (ACAD)

Uli HacksellPresident/CEOThomas H AasenExec VP/CFO/Treasurer
Roger M MillsExec VP:Dev/Chief Medical OfcrGlenn F BaityVP/Secy/General Counsel
Terrence O MooreExec VP/Chief Commercial OfficerLisa BarthelemyDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil